• Title of article

    α2β1 and αVβ1 integrin signaling pathways mediate amyloid-β-induced neurotoxicity

  • Author/Authors

    Sarah Wright، نويسنده , , Nikolay L. Malinin، نويسنده , , Kyle A. Powell، نويسنده , , Ted Yednock، نويسنده , , Russell E. Rydel، نويسنده , , Irene Griswold-Prenner، نويسنده ,

  • Issue Information
    روزنامه با شماره پیاپی سال 2007
  • Pages
    12
  • From page
    226
  • To page
    237
  • Abstract
    Pathological hallmarks of Alzheimerʹs disease are the presence of extracellular amyloid plaques, intracellular neurofibrillary tangles, and neurodegeneration. The principal component of amyloid plaques is the amyloid-β peptide (Aβ). Accumulating evidence indicates that Aβ may play a causal role in Alzheimerʹs disease. In this report, we demonstrate that Aβ deposition and neurotoxicity in human cortical primary neurons are mediated through α2β1 and αVβ1 integrins using specific integrin-blocking antibodies. An aberrant integrin signaling pathway causing the neurotoxicity is mediated through Pyk2. The role of α2β1 and αVβ1 integrins can be extended to another amyloidosis using an amylin in vitro neurotoxicity model. These results indicate that the α2β1 and αVβ1 integrin signaling pathway may be critical components of neurodegeneration in Alzheimerʹs disease and that integrins may recognize and be activated by a shared structural motif of polymerizing amyloidogenic proteins.
  • Keywords
    2 1 and V 1 integrin , Amyloid- , Pyk2 , Neurodegeneration , Alzheimer’s disease
  • Journal title
    Neurobiology of Aging
  • Serial Year
    2007
  • Journal title
    Neurobiology of Aging
  • Record number

    820932